- call +1-201-465-4211
- email sales@mrinsights.biz
Oligonucleotides are short DNA or RNA molecules, oligomers, that have a wide range of applications in genetic testing, research, and forensics. Commonly made in the laboratory by solid-phase chemical synthesis, these small bits of nucleic acids can be manufactured as single-stranded molecules with any user-specified sequence, and so are vital for artificial gene synthesis, polymerase chain reaction (PCR), DNA sequencing, library construction and as molecular probes.
Scope of the Report:
This report studies the Oligonucleotide Pool market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Oligonucleotide Pool market by product type and applications/end industries.
Oligonucleotide therapeutics have attracted drug manufacturers to guarantee lower drug advancement costs, and the capacity to achieve targets that are not achieved by traditional small molecule drugs. Various clinical candidates have progressed, and a few drugs seem balanced for regulatory approvals. Large pharmaceutical organizations appear to once again investing and putting resources into oligonucleotides through authorizing licensing deals, partnerships, and acquisitions.
The global Oligonucleotide Pool market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Oligonucleotide Pool.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Agilent Technologies
Creative Biogene
CustomArray
Integrated DNA Technologies
MYcroarray
Sigma Aldrich
TriLink BioTechnologies
Twist Bioscience
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
DNA Pool
RNA Pool
Market Segment by Applications, can be divided into
Diagnostics
Therapeutics
Research
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Oligonucleotide Pool Market Overview
1.1 Product Overview and Scope of Oligonucleotide Pool
1.2 Classification of Oligonucleotide Pool by Types
1.2.1 Global Oligonucleotide Pool Revenue Comparison by Types (2017-2023)
1.2.2 Global Oligonucleotide Pool Revenue Market Share by Types in 2017
1.2.3 DNA Pool
1.2.4 RNA Pool
1.3 Global Oligonucleotide Pool Market by Application
1.3.1 Global Oligonucleotide Pool Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Diagnostics
1.3.3 Therapeutics
1.3.4 Research
1.4 Global Oligonucleotide Pool Market by Regions
1.4.1 Global Oligonucleotide Pool Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Oligonucleotide Pool Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Oligonucleotide Pool Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Oligonucleotide Pool Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Oligonucleotide Pool Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Oligonucleotide Pool Status and Prospect (2013-2023)
1.5 Global Market Size of Oligonucleotide Pool (2013-2023)
2 Manufacturers Profiles
2.1 Agilent Technologies
2.1.1 Business Overview
2.1.2 Oligonucleotide Pool Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Agilent Technologies Oligonucleotide Pool Revenue, Gross Margin and Market Share (2016-2017)
2.2 Creative Biogene
2.2.1 Business Overview
2.2.2 Oligonucleotide Pool Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Creative Biogene Oligonucleotide Pool Revenue, Gross Margin and Market Share (2016-2017)
2.3 CustomArray
2.3.1 Business Overview
2.3.2 Oligonucleotide Pool Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 CustomArray Oligonucleotide Pool Revenue, Gross Margin and Market Share (2016-2017)
2.4 Integrated DNA Technologies
2.4.1 Business Overview
2.4.2 Oligonucleotide Pool Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Integrated DNA Technologies Oligonucleotide Pool Revenue, Gross Margin and Market Share (2016-2017)
2.5 MYcroarray
2.5.1 Business Overview
2.5.2 Oligonucleotide Pool Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 MYcroarray Oligonucleotide Pool Revenue, Gross Margin and Market Share (2016-2017)
2.6 Sigma Aldrich
2.6.1 Business Overview
2.6.2 Oligonucleotide Pool Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Sigma Aldrich Oligonucleotide Pool Revenue, Gross Margin and Market Share (2016-2017)
2.7 TriLink BioTechnologies
2.7.1 Business Overview
2.7.2 Oligonucleotide Pool Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 TriLink BioTechnologies Oligonucleotide Pool Revenue, Gross Margin and Market Share (2016-2017)
2.8 Twist Bioscience
2.8.1 Business Overview
2.8.2 Oligonucleotide Pool Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Twist Bioscience Oligonucleotide Pool Revenue, Gross Margin and Market Share (2016-2017)
3 Global Oligonucleotide Pool Market Competition, by Players
3.1 Global Oligonucleotide Pool Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Oligonucleotide Pool Players Market Share
3.2.2 Top 10 Oligonucleotide Pool Players Market Share
3.3 Market Competition Trend
4 Global Oligonucleotide Pool Market Size by Regions
4.1 Global Oligonucleotide Pool Revenue and Market Share by Regions
4.2 North America Oligonucleotide Pool Revenue and Growth Rate (2013-2018)
4.3 Europe Oligonucleotide Pool Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Oligonucleotide Pool Revenue and Growth Rate (2013-2018)
4.5 South America Oligonucleotide Pool Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Oligonucleotide Pool Revenue and Growth Rate (2013-2018)
5 North America Oligonucleotide Pool Revenue by Countries
5.1 North America Oligonucleotide Pool Revenue by Countries (2013-2018)
5.2 USA Oligonucleotide Pool Revenue and Growth Rate (2013-2018)
5.3 Canada Oligonucleotide Pool Revenue and Growth Rate (2013-2018)
5.4 Mexico Oligonucleotide Pool Revenue and Growth Rate (2013-2018)
6 Europe Oligonucleotide Pool Revenue by Countries
6.1 Europe Oligonucleotide Pool Revenue by Countries (2013-2018)
6.2 Germany Oligonucleotide Pool Revenue and Growth Rate (2013-2018)
6.3 UK Oligonucleotide Pool Revenue and Growth Rate (2013-2018)
6.4 France Oligonucleotide Pool Revenue and Growth Rate (2013-2018)
6.5 Russia Oligonucleotide Pool Revenue and Growth Rate (2013-2018)
6.6 Italy Oligonucleotide Pool Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Oligonucleotide Pool Revenue by Countries
7.1 Asia-Pacific Oligonucleotide Pool Revenue by Countries (2013-2018)
7.2 China Oligonucleotide Pool Revenue and Growth Rate (2013-2018)
7.3 Japan Oligonucleotide Pool Revenue and Growth Rate (2013-2018)
7.4 Korea Oligonucleotide Pool Revenue and Growth Rate (2013-2018)
7.5 India Oligonucleotide Pool Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Oligonucleotide Pool Revenue and Growth Rate (2013-2018)
8 South America Oligonucleotide Pool Revenue by Countries
8.1 South America Oligonucleotide Pool Revenue by Countries (2013-2018)
8.2 Brazil Oligonucleotide Pool Revenue and Growth Rate (2013-2018)
8.3 Argentina Oligonucleotide Pool Revenue and Growth Rate (2013-2018)
8.4 Colombia Oligonucleotide Pool Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Oligonucleotide Pool by Countries
9.1 Middle East and Africa Oligonucleotide Pool Revenue by Countries (2013-2018)
9.2 Saudi Arabia Oligonucleotide Pool Revenue and Growth Rate (2013-2018)
9.3 UAE Oligonucleotide Pool Revenue and Growth Rate (2013-2018)
9.4 Egypt Oligonucleotide Pool Revenue and Growth Rate (2013-2018)
9.5 Nigeria Oligonucleotide Pool Revenue and Growth Rate (2013-2018)
9.6 South Africa Oligonucleotide Pool Revenue and Growth Rate (2013-2018)
10 Global Oligonucleotide Pool Market Segment by Type
10.1 Global Oligonucleotide Pool Revenue and Market Share by Type (2013-2018)
10.2 Global Oligonucleotide Pool Market Forecast by Type (2018-2023)
10.3 DNA Pool Revenue Growth Rate (2013-2023)
10.4 RNA Pool Revenue Growth Rate (2013-2023)
11 Global Oligonucleotide Pool Market Segment by Application
11.1 Global Oligonucleotide Pool Revenue Market Share by Application (2013-2018)
11.2 Oligonucleotide Pool Market Forecast by Application (2018-2023)
11.3 Diagnostics Revenue Growth (2013-2018)
11.4 Therapeutics Revenue Growth (2013-2018)
11.5 Research Revenue Growth (2013-2018)
12 Global Oligonucleotide Pool Market Size Forecast (2018-2023)
12.1 Global Oligonucleotide Pool Market Size Forecast (2018-2023)
12.2 Global Oligonucleotide Pool Market Forecast by Regions (2018-2023)
12.3 North America Oligonucleotide Pool Revenue Market Forecast (2018-2023)
12.4 Europe Oligonucleotide Pool Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Oligonucleotide Pool Revenue Market Forecast (2018-2023)
12.6 South America Oligonucleotide Pool Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Oligonucleotide Pool Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Oligonucleotide Pool Picture
Table Product Specifications of Oligonucleotide Pool
Table Global Oligonucleotide Pool and Revenue (Million USD) Market Split by Product
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
